Cargando…
Anti-CD133 Antibody Immobilized on the Surface of Stents Enhances Endothelialization
Drug eluting stents successfully reduce restenosis at the cost of delayed reendothelialization. In recent years, a novel concept to enhance reendothelialization using anti-CD34 antibody coated stents which capture circulating progenitor cells (EPCs) has been developed with conflicting clinical resul...
Autores principales: | Li, Jian, Li, Dan, Gong, Feirong, Jiang, Shaoyan, Yu, Hua, An, Yi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3966336/ https://www.ncbi.nlm.nih.gov/pubmed/24734251 http://dx.doi.org/10.1155/2014/902782 |
Ejemplares similares
-
Distinctive effects of CD34- and CD133-specific antibody-coated stents on re-endothelialization and in-stent restenosis at the early phase of vascular injury
por: Wu, Xue, et al.
Publicado: (2015) -
Anti-Inflammatory Effects of Arsenic Trioxide Eluting Stents in a Porcine Coronary Model
por: Shen, Li, et al.
Publicado: (2013) -
Bioaffinity-based surface immobilization of antibodies to capture endothelial colony-forming cells
por: Boulanger, Mariève D., et al.
Publicado: (2022) -
Immobilization of Radionuclide (133)Cs by Magnesium Silicate Hydrate Cement
por: Zhang, Tingting, et al.
Publicado: (2019) -
Expressions and clinical significances of CD133 protein and CD133 mRNA in primary lesion of gastric adenocacinoma
por: Yu, Ji-wei, et al.
Publicado: (2010)